These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3249763)

  • 1. Alzheimer's Disease Assessment Scale (ADAS).
    Mohs RC; Cohen L
    Psychopharmacol Bull; 1988; 24(4):627-8. PubMed ID: 3249763
    [No Abstract]   [Full Text] [Related]  

  • 2. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spanish adaptation of the Alzheimer's disease assessment scale (ADAS)].
    Manzano JM; Llorca G; Ledesma A; López-Ibor JJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(2):64-70. PubMed ID: 8079673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
    Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
    Graham DP; Cully JA; Snow AL; Massman P; Doody R
    Alzheimer Dis Assoc Disord; 2004; 18(4):236-40. PubMed ID: 15592137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical rating scale for symptoms of psychosis in Alzheimer's disease.
    Reisberg B; Ferris SH
    Psychopharmacol Bull; 1985; 21(1):101-4. PubMed ID: 3983330
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months.
    Rockwood K; Dai D; Mitnitski A
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):207-14. PubMed ID: 17621382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome measures for probable vascular dementia and Alzheimer's disease with cerebrovascular disease.
    Gauthier S; Ferris S
    Int J Clin Pract Suppl; 2001 May; (120):29-39. PubMed ID: 11406924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Scales used for therapeutic trials in Alzheimer's disease].
    Vercelletto M
    Rev Neurol (Paris); 2002 Sep; 158(8-9):857-61. PubMed ID: 12386538
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS-K).
    Youn JC; Lee DY; Kim KW; Lee JH; Jhoo JH; Lee KU; Ha J; Woo JI
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):797-803. PubMed ID: 12221651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for nursing management in Alzheimer's care.
    Wondolowski C; Chartock P
    J Adv Med Surg Nurs; 1989 Mar; 1(2):76-87. PubMed ID: 2746183
    [No Abstract]   [Full Text] [Related]  

  • 14. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.
    Mohs RC; Rosen WG; Davis KL
    Psychopharmacol Bull; 1983; 19(3):448-50. PubMed ID: 6635122
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vascular factors and the psychopathological picture in Alzheimer's disease].
    Idzan LB; Bidzan M
    Psychiatr Pol; 2006; 40(5):823-31. PubMed ID: 17217228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving accuracy in the diagnosis of Alzheimer's disease.
    Shore D; Overman CA; Wyatt RJ
    J Clin Psychiatry; 1983 Jun; 44(6):207-12. PubMed ID: 6853459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
    Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting depression in Alzheimer's disease: evaluation of four different scales.
    Müller-Thomsen T; Arlt S; Mann U; Mass R; Ganzer S
    Arch Clin Neuropsychol; 2005 Mar; 20(2):271-6. PubMed ID: 15708735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
    Ylikoski R; Jokinen H; Andersen P; Salonen O; Madureira S; Ferro J; Barkhof F; van der Flier W; Schmidt R; Fazekas F; Scheltens P; Waldemar G; Salvadori E; Pantoni L; Inzitari D; Erkinjuntti T;
    Dement Geriatr Cogn Disord; 2007; 24(2):73-81. PubMed ID: 17565216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.